| ￥5800 | |
| Z04381-100 | |
|
|
|
|
|
|
|
|
|
| Species | Cynomolgus/Rhesus macaque | ||||
| Protein Construction |
|
||||
| Conjugate | Biotin | ||||
| Purity | > 95% as determined by BisTris PAGE | ||||
| Endotoxin Level | Less than 1EU per μg by the LAL method. | ||||
| Biological Activity | Measured by its binding ability in a functional ELISA.Test result was comparable to standard batch. | ||||
| Expression System | HEK293 | ||||
| Theoretical Molecular Weight | 26 kDa | ||||
| Apparent Molecular Weight | Due to glycosylation, the protein migrates to 35-40 kDa based on Bis-Tris PAGE result. | ||||
| Formulation | Lyophilized from 0.22 μm filtered solution in PBS (pH 7.4). | ||||
| Reconstitution | Centrifuge the tube before opening. Reconstituting to a concentration more than 100 μg/ml is recommended. Dissolve the lyophilized protein in distilled water. | ||||
| Storage & Stability | Upon receiving, the product remains stable for 6 months at -20℃ or below. Upon reconstitution, the product should be stable for 3 months at -80℃. Avoid repeated freeze-thaw cycles. |
Immobilized PD-L1/B7-H1 [Biotin], His, Cynomolgus/Rhesus macaque, His Tag at 0.5 μg/ml (100 μl/Well) on the plate. Dose response curve for Anti-PD-L1 Antibody, hFc Tag with the EC50 of 4.0ng/ml determined by ELISA. »
The purity of PD-L1/B7-H1 [Biotin], His, Cynomolgus/Rhesus macaque is greater than 95% as determined by SEC-HPLC. »
PD-L1/B7-H1 [Biotin], His, Cynomolgus/Rhesus macaque on Bis-Tris PAGE under reduced conditions. The purity is greater than 95%. »
| Target Background | B7-H1, also known as PD-L1 and CD274, is an approximately 65 kDa transmembrane glycoprotein in the B7 family of immune regulatory molecules. PD-L1 has been identified as the ligand for the immunoinhibitory receptor programmed death-1(PD1/PDCD1) and has been demonstrated to play a role in the regulation of immune responses and peripheral tolerance. |
| Synonyms | CD274; PDL1; PD-L1; PD-L1B7 homolog 1;B7-H; B7H1; B7-H1; PDCD1L1; PDCD1LG1 |
For research use only. Not intended for human or animal clinical trials, therapeutic or diagnostic use.
